leflunomide has been researched along with Anemia, Aplastic in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wüsthof, M | 1 |
| Smirnova, A | 1 |
| Bacher, U | 1 |
| Kröger, N | 1 |
| Zander, AR | 1 |
| Schuch, G | 1 |
| Bokemeyer, C | 1 |
1 other study available for leflunomide and Anemia, Aplastic
| Article | Year |
|---|---|
Severe aplastic anaemia following leflunomide therapy.
Topics: Adult; Anemia, Aplastic; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Le | 2010 |